CN1090954C - Gastritis capsule - Google Patents
Gastritis capsule Download PDFInfo
- Publication number
- CN1090954C CN1090954C CN99104281A CN99104281A CN1090954C CN 1090954 C CN1090954 C CN 1090954C CN 99104281 A CN99104281 A CN 99104281A CN 99104281 A CN99104281 A CN 99104281A CN 1090954 C CN1090954 C CN 1090954C
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- rhizoma
- root
- gastritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese patent medicine for treating gastritis, which is prepared from 4.5 wt% to 5.5 wt% of astragalus root, 3.5 wt% to 4.5 wt% of pilose asiabell root, 3.5 wt% to 4.5 wt% of tuckahoe, 6.5 wt% to 7.5 wt% of slender dutchmanspipe root, 0.8 wt% to 1.2 wt% of coptis, 0.6 wt% to 1 wt% of evodia, 4.5 wt% to 5.5 wt% of Chinese pulsatilla root, 4.5 wt% to 5.5 wt% of fructus toosendan, 3.5 wt% to 4.5 wt% of rhizoma corydalis, 2.5 wt% to 3.5 wt% of langpian, 3.5 wt% to 4.5 wt% of white atractylodes rhizome, 3.5 wt% to 4.5 wt%of immature orange fruit, 2.5 wt% to 3.5 wt% of chicken gizzard-membrane, 2.5 wt% to 3.5 wt% of rhizoma zedoariae, 1.3 wt% to 1.7 wt% of olibanum, 2.5 wt% to 3.5 wt% of raw sanguisorba, 3.5 wt% to 4.5 wt% of bletilla striata, 2.5 wt% to 3.5 wt% of gallnut, 3.5 wt% to 4.5 wt% of cuttlefish bone, 1.5 wt% to 2.5 wt% of cassia bark , 1.3 wt% to 1.7 wt% of liquorice, etc. The Chinese patent medicine has conspicuous effects of eliminating, expelling and killing helicobacter pylori, promoting the rehabilitation of gastric pathologic change and promoting the restoration and the concrescence of gastric mucosa.
Description
The invention belongs to a kind of Chinese patent medicine for the treatment of gastritis.
Studies show that through the medical expert: helicobacter pylori is to cause the important pathogenic pathogen of various disease of stomach (chronic active gastritis, gastric ulcer, duodenal ulcer, gastric cancer etc.).Eliminating helicobacter pylori infections is a research topic of radical cure chronic active gastritis, although there is the multiple stomach new drug of controlling to come out, through clinical verification, effect is also not exclusively desirable.And helicobacter pylori infections acts on the skin of mucosa tissue, forms cytoclasis inflammation tissue, discharges the inflammatory mediator of brute force, produces a series of inflammatory pains, dyspepsia, symptom that power is not good enough.
The present invention's purpose is to provide a kind of new drug for the treatment of gastritis, and useful tachypnea is moving, the effect of detoxicating, killing bacteria, blood-activating analgetic, protection mucosa.
For reaching above-mentioned purpose, the technical scheme that the present invention takes is: the present invention, selectes following Chinese medicinal ingredients, and is equipped with rational proportion (weight ratio) through pharmacology analysis research and clinical trial according to the root of gastritis disease:
The Radix Astragali: Radix Codonopsis: Poria: Radix Aristolochiae: Rhizoma Coptidis: Fructus Evodiae: the Radix Pulsatillae: Fructus Toosendan, Rhizoma Corydalis: bulky: the Rhizoma Atractylodis Macrocephalae; Fructus Aurantii Immaturus: Endothelium corneum: Rhizoma Curcumae: Olibanum: Radix Sangusorbae: the Pseudobulbus Bletillae (Rhizoma Bletillae): Galla Chinensis: Endoconcha Sepiae: Cortex Cinnamomi: Radix Glycyrrhizae=4.5~5.5: 3.5~4.5: 3.5~4.5: 6.5~7.5: 0.8~1.2: 0.6~1: 4.5~5.5: 4.5~5.5: 3.5~4.5: 2.5~3.5: 3.5~4.5: 3.5~4.5: 2.5~3.5 :~2.5~3.5: 1.3~1.7: 2.5~3.5: 3.5~4.5: 2.5~3.5: 3.5~4.5: 1.5~2.5: 1.3~1.7.
Its best proportioning is: 5: 4: 4: 7: 1: 0.8: 5: 5: 4: 3: 4: 4: 3: 3: 1.5: 3: 4: 3: 4: 2: 1.5.
Pathological analysis and compatibility meaning: at present, comparatively general chronic active gastritis exists obstinate, the situation of empty condition under day, thereby causes gastric qi deficient, make helicobacter pylori infections become the stomach lining inflammation infringement to be on the rise thoroughly, formed just more empty and evil complex situations of more containing.Based on above-mentioned pathological change, in time adjust gastric qi, the strong moving function of priority restores taste has only gastric qi strong, and be expected the day after tomorrow, gastric qi weakness, the empty sick calamity of body.Selected the Radix Astragali, Radix Codonopsis, Poria, the Rhizoma Atractylodis Macrocephalae, Fructus Aurantii Immaturus etc. in the event side, training invigorating middle warmer gas is as a means of the change source; Next cooperates the detoxicating, killing bacteria medicine, selected Rhizoma Coptidis, Radix Aristolochiae, the Radix Pulsatillae, Fructus Toosendan, bulky etc., confirm according to another pharmacological research: the detoxicating, killing bacteria medicine has disease-resistant source action of microorganisms, can directly kill helicobacter pylori, promotes Gastric Diseases by Spraying to take a turn for the better and struvite change; The 3rd, blood circulation promoting and blood stasis dispelling, the protection mucosa, according to the fine sem observation of stomach, chronic gastritis has struvite ecchymosis and sheath sample hypertrophy in various degree, and mucosal erosion also has oozing of blood.Learn from clinical, give birth to slowly the gastritis sufferer again more see with scorching hot in the stomach, noisy twinge, feeling of fullness stop up, belch is done frequently, the sign of the dim ecchymosis of tongue, deep and stringy pulse and blood stasis network resistance such as puckery.Cooperate Rhizoma Corydalis, Olibanum, Rhizoma Curcumae with the disperse blood stasis and dredge collateral pain relieving for this reason.Assistant promotes the reparation and the healing of gastric mucosa with Radix Sangusorbae, Galla Chinensis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Endoconcha Sepiae, and effect is remarkable.
Beneficial effect of the present invention is: can produce and remove the cytotoxin helicobacter pylori, make gastric epithelial cell cavity, necrosis occur, Peptic Ulcers becomes to correct, and stomach erosive inflammation is all disappeared, and the protection gastrointestinal mucosa heals the ulcer focus rapidly.Through clinical trial, total effective rate of the present invention reaches 98%, and cure rate is 92.6%.
Embodiment one
The Radix Astragali 50 gram, Radix Codonopsis 40 grams, Poria 40 grams, Radix Aristolochiae 70 grams, Rhizoma Coptidis 10 grams, Fructus Evodiae 8 grams, the Radix Pulsatillae 50 grams, Fructus Toosendan 50 grams, Rhizoma Corydalis 40 grams, bulky 30 gram, the Rhizoma Atractylodis Macrocephalae 40 grams, Fructus Aurantii Immaturus 40 grams, Endothelium corneum 30 grams, Rhizoma Curcumae 30 grams, Olibanum 15 grams, Radix Sangusorbae 30 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 40 grams, Galla Chinensis 30 grams, Endoconcha Sepiae 40 grams, Cortex Cinnamomi 20 grams, Radix Glycyrrhizae 15 grams.
Embodiment two
The Radix Astragali 51 gram, Radix Codonopsis 42 grams, Poria 38 grams, Radix Aristolochiae 65 grams, Rhizoma Coptidis 11 grams, Fructus Evodiae 9 grams, the Radix Pulsatillae 54 grams, Fructus Toosendan 47 grams, Rhizoma Corydalis 39 grams, bulky 32 gram, the Rhizoma Atractylodis Macrocephalae 43 grams, Fructus Aurantii Immaturus 42 grams, Endothelium corneum 28 grams, Rhizoma Curcumae 31 grams, Olibanum 16 grams, Radix Sangusorbae 32 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 42 grams, Galla Chinensis 31 grams, Endoconcha Sepiae 45 grams, Cortex Cinnamomi 18 grams, Radix Glycyrrhizae 14 grams.
Embodiment three
The Radix Astragali 49 gram, Radix Codonopsis 39 grams, Poria 42 grams, Radix Aristolochiae 75 grams, Rhizoma Coptidis 9 grams, Fructus Evodiae 7 grams, the Radix Pulsatillae 48 grams, Fructus Toosendan 53 grams, Rhizoma Corydalis 41 grams, bulky 31 gram, the Rhizoma Atractylodis Macrocephalae 38 grams, Fructus Aurantii Immaturus 39 grams, Endothelium corneum 32 grams, Rhizoma Curcumae 29 grams, Olibanum 14 grams, Radix Sangusorbae 28 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 39 grams, Galla Chinensis 29 grams, Endoconcha Sepiae 38 grams, Cortex Cinnamomi 22 grams, Radix Glycyrrhizae 16 grams.
With embodiment one, embodiment two, embodiment three thing that makes up a prescription, in the capsule of 0.5 gram of packing into after the pulverizing.The patient obeys three every day, obeys 5 every day and gets final product.
Claims (1)
1. gastritis capsule, it is characterized in that it is made up of following components in weight percentage: the Radix Astragali, Radix Codonopsis, Poria, Radix Aristolochiae, Rhizoma Coptidis, Fructus Evodiae, the Radix Pulsatillae, Fructus Toosendan, Rhizoma Corydalis, bulky, the Rhizoma Atractylodis Macrocephalae, Fructus Aurantii Immaturus, Endothelium corneum, Rhizoma Curcumae, Olibanum, Radix Sangusorbae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Galla Chinensis, Endoconcha Sepiae, Cortex Cinnamomi and Radix Glycyrrhizae, each set of dispense ratio is 4.5~5.5: 3.5~4.5: 3.5~4.5: 6.5~7.5: 0.8~1.2: 0.6~1: 4.5~5.5: 4.5~5.5: 3.5~4.5: 2.5~3.5: 3.5~4.5: 3.5~4.5: 2.5~3.5 :~2.5~3.5: 1.3~1.7: 2.5~3.5: 3.5~4.5: 2.5~3.5: 3.5~4.5: 1.5~2.5: 1.3~1.7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99104281A CN1090954C (en) | 1999-05-13 | 1999-05-13 | Gastritis capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99104281A CN1090954C (en) | 1999-05-13 | 1999-05-13 | Gastritis capsule |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1273845A CN1273845A (en) | 2000-11-22 |
CN1090954C true CN1090954C (en) | 2002-09-18 |
Family
ID=5271614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99104281A Expired - Fee Related CN1090954C (en) | 1999-05-13 | 1999-05-13 | Gastritis capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1090954C (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1301125C (en) * | 2003-09-12 | 2007-02-21 | 贵州苗药雪胆胃肠丸科技中心 | Medicine for treating gastrointestinal tract disease |
CN1327883C (en) * | 2005-04-04 | 2007-07-25 | 王双元 | Traditional Chinese medicine for treating stomach disease |
CN102671098B (en) * | 2012-05-15 | 2014-01-08 | 宋协勘 | Traditional Chinese medicine for treating peptic ulcer |
CN102755601B (en) * | 2012-08-08 | 2014-01-15 | 杨洪义 | Traditional Chinese medicine for treating stomach illness and preparation method thereof |
CN107536994A (en) * | 2017-09-13 | 2018-01-05 | 徐秀环 | Powder medicine for treating gastritis and gastric ulcer |
CN107802810A (en) * | 2017-11-17 | 2018-03-16 | 闫柏林 | Composition for treating stomach trouble and preparation method thereof |
CN107897452A (en) * | 2017-12-29 | 2018-04-13 | 广东德海农业有限公司 | A kind of lemon tea for promoting gastric mucosal |
CN108324921B (en) * | 2018-05-18 | 2021-02-19 | 宁波御坊堂生物科技有限公司 | A pharmaceutical composition with cyst removing and gastric mucosa protecting effects, and its preparation method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1075090A (en) * | 1993-01-09 | 1993-08-11 | 朝阳市第二医院 | Treatment chronic gastritis Chinese medicine stomachic tablet and preparation method thereof |
CN1094959A (en) * | 1993-05-13 | 1994-11-16 | 山东省医学科学院基础医学研究所 | A kind of Chinese medicine for the treatment of gastropathy |
CN1162479A (en) * | 1997-05-08 | 1997-10-22 | 贾喜库 | Powder for curing gastritis and preparation thereof |
-
1999
- 1999-05-13 CN CN99104281A patent/CN1090954C/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1075090A (en) * | 1993-01-09 | 1993-08-11 | 朝阳市第二医院 | Treatment chronic gastritis Chinese medicine stomachic tablet and preparation method thereof |
CN1094959A (en) * | 1993-05-13 | 1994-11-16 | 山东省医学科学院基础医学研究所 | A kind of Chinese medicine for the treatment of gastropathy |
CN1162479A (en) * | 1997-05-08 | 1997-10-22 | 贾喜库 | Powder for curing gastritis and preparation thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1273845A (en) | 2000-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102139030B (en) | Oral Chinese herbal preparation for treating gingivitis and preparation method thereof | |
CN102526616B (en) | Chinese medicinal herb pills for treating cholecystitis and gallstone | |
CN102512630B (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
CN1090954C (en) | Gastritis capsule | |
CN105213941A (en) | A kind of Chinese medicine composition being used for the treatment of infantile diarrhea and preparation method thereof | |
CN101347594A (en) | Method for preparing Chinese medicine for treating kidney-yang deficiency type diarrhea | |
CN1069527C (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
CN1172690C (en) | Chinese medicine powder for treating tetanic rachitis | |
CN101468194A (en) | Medicine composition for treating colitis and method of making the same | |
CN103263601A (en) | Chinese herbal preparation for accelerating fracture post-operation healing and preparation method of Chinese herbal preparation | |
CN102793904B (en) | Preparation method for traditional Chinese medicine lotion for treatment of confusing-type closed fracture | |
CN1219525C (en) | Chinese medicine for treating women's ovary cancer and uterine myoma | |
CN104258308A (en) | Traditional Chinese medicine preparation for treating cholelithiasis | |
CN102451315A (en) | Preparation method for traditional Chinese drug preparation for treating acute cholecystitis | |
CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
CN103007238B (en) | Traditional Chinese medicine composition for treating decubitus ulcers | |
CN105031267A (en) | Prescription for treating periodontitis and preparation method | |
CN105943924A (en) | Traditional Chinese medicine for treating gallbladder fire exuberance syndrome type multiple gall-stone | |
CN105561182A (en) | Traditional Chinese medicinal preparation for treating renal calculus, and preparation method thereof | |
CN1966005A (en) | Medicament for treating cervical spondylosis | |
CN105560893A (en) | Traditional Chinese medicine composition for treating periodontitis | |
CN104491255A (en) | Traditional Chinese medicine preparation for treating acute cholecystitis | |
CN105106692A (en) | Traditional Chinese medicinal composition for gallstone postoperative recovery and preparation method of traditional Chinese medicinal composition | |
CN1099633A (en) | Baicao antiphlogistic pill | |
CN1175852C (en) | Medicine for treating hyperosteogeny |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |